FDA uncovers data manipulation at Immunomedics plant making cancer drug

FDA uncovers data manipulation at Immunomedics plant making cancer drug

Source: 
Fierce Pharma
snippet: 

The FDA has released a Form 483 from the inspection of the Immunomedics plant showing big issues with data integrity at the Morris Plains, New Jersey, plant where sacituzumab govitecan is being made.